These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes. Bandiera FC; Ross KC; Taghavi S; Delucchi K; Tyndale RF; Benowitz NL Nicotine Tob Res; 2015 Sep; 17(9):1167-72. PubMed ID: 25555385 [TBL] [Abstract][Full Text] [Related]
64. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Chenoweth MJ; Novalen M; Hawk LW; Schnoll RA; George TP; Cinciripini PM; Lerman C; Tyndale RF Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1773-82. PubMed ID: 25012994 [TBL] [Abstract][Full Text] [Related]
65. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial. Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151 [TBL] [Abstract][Full Text] [Related]
67. Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - role of gene-gene interaction, personality, and environmental factors. Greenbaum L; Kanyas KS; Rigbi A; Alkelai A; Kohn Y; Lerer B Hum Psychopharmacol; 2010 Nov; 25(7-8):536-42. PubMed ID: 21312287 [TBL] [Abstract][Full Text] [Related]
68. CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women. Jones SK; Alberg AJ; Wallace K; Froeliger B; Carpenter MJ; Wolf BJ Nicotine Tob Res; 2023 May; 25(6):1164-1173. PubMed ID: 36794842 [TBL] [Abstract][Full Text] [Related]
69. The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. Saccone NL; Baurley JW; Bergen AW; David SP; Elliott HR; Foreman MG; Kaprio J; Piasecki TM; Relton CL; Zawertailo L; Bierut LJ; Tyndale RF; Chen LS; Nicotine Tob Res; 2018 Mar; 20(4):403-413. PubMed ID: 28472521 [TBL] [Abstract][Full Text] [Related]
70. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. King DP; Paciga S; Pickering E; Benowitz NL; Bierut LJ; Conti DV; Kaprio J; Lerman C; Park PW Neuropsychopharmacology; 2012 Feb; 37(3):641-50. PubMed ID: 22048466 [TBL] [Abstract][Full Text] [Related]
71. Molecular mechanisms underlying behaviors related to nicotine addiction. Picciotto MR; Kenny PJ Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a012112. PubMed ID: 23143843 [TBL] [Abstract][Full Text] [Related]